Variant report
Variant | nsv522663 |
---|---|
Chromosome Location | chr5:89995803-89998454 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:89996062..89999170-chr5:90000730..90003176,4 | K562 | blood: | |
2 | chr5:89994085..89995994-chr5:89996980..89998521,2 | K562 | blood: | |
3 | chr5:89996062..89998352-chr5:90001342..90003176,2 | K562 | blood: | |
4 | chr5:89994085..89995994-chr5:89996980..89998521,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17622455 | chr5:89995803-89995804 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs150269158 | chr5:89995838-89995839 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549598725 | chr5:89995845-89995846 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569477812 | chr5:89995907-89995908 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78526168 | chr5:89995914-89995915 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142321078 | chr5:89996051-89996052 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116691038 | chr5:89996060-89996061 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533948059 | chr5:89996084-89996085 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576408102 | chr5:89996112-89996113 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553784074 | chr5:89996142-89996143 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186879416 | chr5:89996183-89996184 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536395012 | chr5:89996225-89996226 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555262054 | chr5:89996229-89996230 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575403771 | chr5:89996300-89996301 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190900085 | chr5:89996322-89996323 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183321433 | chr5:89996328-89996329 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16869013 | chr5:89996329-89996330 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs188012638 | chr5:89996350-89996351 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560239825 | chr5:89996401-89996402 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145973996 | chr5:89996422-89996423 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554749781 | chr5:89996423-89996424 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1878879 | chr5:89996445-89996446 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs1878880 | chr5:89996490-89996491 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs139842822 | chr5:89996529-89996530 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551754530 | chr5:89996590-89996591 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557648953 | chr5:89996593-89996594 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141748757 | chr5:89996597-89996598 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374265847 | chr5:89996599-89996600 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1878881 | chr5:89996625-89996626 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs75917359 | chr5:89996627-89996628 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536305579 | chr5:89996638-89996639 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556619487 | chr5:89996680-89996681 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs67956713 | chr5:89996684-89996685 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs144573131 | chr5:89996746-89996747 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148452953 | chr5:89996750-89996751 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35417003 | chr5:89996760-89996761 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577998261 | chr5:89996775-89996776 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142724746 | chr5:89996804-89996805 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192152978 | chr5:89996897-89996898 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113918010 | chr5:89996924-89996925 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573684737 | chr5:89996938-89996939 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545743465 | chr5:89996941-89996942 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17622555 | chr5:89996966-89996967 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs575880952 | chr5:89996981-89996982 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6865858 | chr5:89996984-89996985 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs10514332 | chr5:89997048-89997049 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs185340584 | chr5:89997057-89997058 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565184808 | chr5:89997058-89997059 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs151004129 | chr5:89997128-89997129 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546723632 | chr5:89997141-89997142 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:89950400-90033400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr5:89979200-90002600 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr5:89982000-90004600 | Weak transcription | Fetal Brain Female | brain |
4 | chr5:89987000-90001200 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr5:89987800-90007200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr5:89990600-90001200 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr5:89991200-90001000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr5:89991800-90014000 | Strong transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr5:89992400-89999800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:89993600-90001200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr5:89994600-89997800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr5:89994600-90001600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr5:89994800-89999200 | Weak transcription | K562 | blood |
14 | chr5:89995000-90001600 | Weak transcription | Brain Germinal Matrix | brain |
15 | chr5:89995000-90025800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr5:89995200-89996400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
17 | chr5:89995400-89997800 | Strong transcription | HUES64 Cell Line | embryonic stem cell |
18 | chr5:89995600-89996200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
19 | chr5:89995600-89998800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr5:89996200-89996400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr5:89996600-89996800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
22 | chr5:89997800-89999600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
23 | chr5:89997800-90017600 | Strong transcription | HUES48 Cell Line | embryonic stem cell |